Get the Stockscreener App
3.97
4.34%
-0.18
Novavax, Inc. Stock (NVAX) Forecast
The Novavax, Inc. (NVAX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $19.45, representing a +389.97% increase from the current price of $3.97. The highest analyst price target is $19.22, and the lowest is $19.68.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NVAX Price Target
Average 19.76
(+397.65% Upside)
Is Novavax, Inc. (NVAX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.02 | Neutral |
| STOCH(9,6) | 34.74 | Neutral |
| STOCHRSI(14) | 61.29 | Neutral |
| MACD(12,26) | -0.1936 | Buy |
| ADX(14) | 9.5051 | Neutral |
| William %R | -75.65 | Neutral |
| CCI(14) | -50.45 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.0564
Sell
|
4.1148
Sell
|
| MA20 |
4.2667
Sell
|
4.2631
Sell
|
| MA50 |
4.6915
Sell
|
4.5237
Sell
|
| MA100 |
4.6937
Sell
|
4.9186
Sell
|
| MA200 |
6.0223
Sell
|
5.7996
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NVAX could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on NVAX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.02 indicates that NVAX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 34.74 indicates that NVAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 61.29 indicates that NVAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 9.5051 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -50.45 indicates that NVAX is still oversold but not to an extreme extent.
Long-term NVAX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Novavax, Inc. financial reports and earnings history, Novavax, Inc. (NVAX) stock could reach $49.82 by 2030, $19.09 by 2040 and $61.58 by 2050. See the projected annual prices until 2050 of the Novavax, Inc. stock below:
- Novavax, Inc. (NVAX) is expected to reach an average price of $4.2608 in 2035, with a high prediction of $4.0218 and a low estimate of $4.1748. This indicates an $7.32% rise from the last recorded price of $3.97.
- Novavax, Inc. (NVAX) stock is projected to chart a bullish course in 2040, with an average price target of $19.41, representing an $389.00% surge from its current level. The forecast ranges from a conservative $18.07 to a sky-high $19.09.
- Our analysts predict Novavax, Inc. (NVAX) to jump 242.92% by 2045, soaring from $4.6599 to an average price of $13.61, potentially reaching $15.09. While $4.6599 is the low estimate, the potential upside is significant.
- Novavax, Inc. (NVAX) stock is expected to climb by 2050, reaching an average of $15.12, a $280.78% jump from its current level. However, a wide range of estimates exists, with high and low targets of $61.58 and $8.768, respectively, highlighting the market's uncertainty.
Novavax, Inc. Stock (NVAX) Year by Year Forecast
Novavax, Inc. Stock (NVAX) Price Forecast for 2024
Our forecast for NVAX stock price in 2024 now indicates an average price target of $13.23 with a high forecast of $24.13 and a low forecast of $2.327. The average prediction reflects an increase of +233.18% from the last recorded price of $3.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $20.38 | $19.68 | $19.22 | +413.47% |
| June, 2024 | $23.72 | $23.62 | $23.30 | +497.41% |
| July, 2024 | $23.81 | $23.68 | $23.50 | +499.78% |
| August, 2024 | $24.25 | $24.03 | $24.13 | +510.77% |
| September, 2024 | $22.20 | $22.16 | $23.89 | +459.19% |
| October, 2024 | $22.08 | $21.48 | $21.82 | +456.07% |
| November, 2024 | $22.87 | $22.65 | $22.49 | +476.12% |
| December, 2024 | $22.81 | $22.68 | $22.72 | +474.67% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2025
Novavax, Inc. Stock (NVAX) is expected to reach an average price of $85.50 in 2025, with a high prediction of $166.42 and a low estimate of $4.5728. This indicates an +2,054% rise from the last recorded price of $3.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $22.51 | $22.29 | $22.70 | +467.01% |
| February, 2025 | $21.74 | $22.30 | $22.36 | +447.64% |
| March, 2025 | $18.83 | $19.14 | $21.34 | +374.28% |
| April, 2025 | $12.87 | $15.39 | $17.52 | +224.30% |
| May, 2025 | $11.60 | $12.07 | $12.22 | +192.21% |
| June, 2025 | $6.3433 | $5.6168 | $9.2873 | +59.78% |
| July, 2025 | $22.03 | $4.5728 | $37.40 | +454.93% |
| August, 2025 | $41.18 | $16.59 | $42.33 | +937.40% |
| September, 2025 | $117.23 | $35.67 | $121.27 | +2,853% |
| October, 2025 | $123.63 | $89.63 | $166.42 | +3,014% |
| November, 2025 | $70.42 | $64.15 | $132.96 | +1,674% |
| December, 2025 | $81.56 | $60.80 | $104.22 | +1,954% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2026
The predicted value for Novavax, Inc. (NVAX) in 2026 is set at an average of $183.31. Estimates vary from a peak of $311.51 to a trough of $55.11, indicating an +4,517% surge from the present price of $3.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $59.04 | $56.83 | $100.06 | +1,387% |
| February, 2026 | $104.40 | $55.11 | $110.71 | +2,530% |
| March, 2026 | $108.51 | $85.10 | $129.39 | +2,633% |
| April, 2026 | $106.53 | $88.37 | $116.94 | +2,583% |
| May, 2026 | $257.80 | $101.38 | $311.51 | +6,394% |
| June, 2026 | $162.51 | $127.50 | $257.16 | +3,993% |
| July, 2026 | $208.11 | $145.68 | $208.86 | +5,142% |
| August, 2026 | $124.24 | $98.26 | $244.62 | +3,029% |
| September, 2026 | $155.82 | $122.47 | $211.10 | +3,825% |
| October, 2026 | $170.57 | $155.03 | $204.28 | +4,196% |
| November, 2026 | $239.72 | $154.27 | $242.45 | +5,938% |
| December, 2026 | $234.31 | $195.54 | $244.30 | +5,802% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Novavax, Inc. (NVAX) is $141.40, with a high forecast of $260.71 and a low forecast of $22.09. This indicates an +3,462% increase from the last price of $3.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $190.24 | $181.19 | $260.71 | +4,692% |
| February, 2027 | $118.15 | $104.92 | $175.69 | +2,876% |
| March, 2027 | $202.01 | $113.75 | $205.76 | +4,988% |
| April, 2027 | $201.73 | $122.57 | $213.13 | +4,981% |
| May, 2027 | $69.53 | $69.43 | $221.00 | +1,651% |
| June, 2027 | $75.69 | $51.35 | $86.64 | +1,807% |
| July, 2027 | $57.34 | $54.94 | $76.62 | +1,344% |
| August, 2027 | $60.41 | $51.54 | $71.41 | +1,422% |
| September, 2027 | $31.54 | $28.60 | $63.84 | +694.37% |
| October, 2027 | $42.13 | $27.98 | $49.79 | +961.22% |
| November, 2027 | $38.98 | $22.09 | $44.52 | +881.81% |
| December, 2027 | $42.11 | $35.36 | $64.36 | +960.75% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2028
In 2028, Novavax, Inc. (NVAX) is projected to reach an average price of $26.14, with a high projection of $52.28 and a low estimate of $0.01. This indicates an +558.51% rise from the last price of $3.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $24.37 | $23.94 | $52.28 | +513.84% |
| February, 2028 | $20.24 | $16.77 | $26.15 | +409.91% |
| March, 2028 | $5.1975 | $5.1225 | $21.99 | +30.92% |
| April, 2028 | $11.54 | $4.991 | $13.83 | +190.72% |
| May, 2028 | $6.229 | $5.2967 | $15.21 | +56.90% |
| June, 2028 | $0.227 | $0.327 | $8.5695 | -94.28% |
| July, 2028 | $1.8705 | $0.01 | $4.187 | -52.88% |
| August, 2028 | $0.9745 | $0.341 | $3.2675 | -75.45% |
| September, 2028 | $2.1515 | $0.317 | $0.976 | -45.81% |
| October, 2028 | $0.9561 | $0.5725 | $2.1245 | -75.92% |
| November, 2028 | $0.6201 | $0.0904 | $3.5301 | -84.38% |
| December, 2028 | $0.1641 | $0.0441 | $0.7736 | -95.87% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2029
The 2029 price forecast for Novavax, Inc. Stock (NVAX) is $24.80 on average, with a high prediction of $49.50 and a low estimate of $0.0884. This represents an +524.56% increase from the previous price of $3.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.2416 | $0.0884 | $1.2561 | -93.91% |
| February, 2029 | $2.6656 | $0.4051 | $3.2851 | -32.86% |
| March, 2029 | $1.8096 | $0.4176 | $3.3596 | -54.42% |
| April, 2029 | $1.3571 | $0.9511 | $4.3401 | -65.82% |
| May, 2029 | $1.0311 | $0.6011 | $2.6276 | -74.03% |
| June, 2029 | $1.2151 | $0.7846 | $2.4651 | -69.39% |
| July, 2029 | $1.0126 | $0.4621 | $1.5786 | -74.49% |
| August, 2029 | $26.73 | $0.4796 | $25.53 | +573.38% |
| September, 2029 | $18.98 | $20.36 | $18.97 | +378.21% |
| October, 2029 | $23.45 | $17.21 | $17.85 | +490.68% |
| November, 2029 | $50.78 | $47.48 | $49.50 | +1,179% |
| December, 2029 | $49.54 | $49.62 | $49.50 | +1,148% |
Novavax, Inc. Stock (NVAX) Price Forecast for 2030
Novavax, Inc. Stock (NVAX) is expected to reach an average price of $46.71 in 2030, with a high forecast of $52.73 and a low forecast of $40.70. This signifies an +1,077% surge from the last price of $3.97.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $52.89 | $49.99 | $49.82 | +1,232% |
| February, 2030 | $52.55 | $53.01 | $52.73 | +1,224% |
| March, 2030 | $52.77 | $52.77 | $52.65 | +1,229% |
| April, 2030 | $52.66 | $52.72 | $52.71 | +1,226% |
| May, 2030 | $50.32 | $50.34 | $52.04 | +1,168% |
| June, 2030 | $49.82 | $49.32 | $49.84 | +1,155% |
| July, 2030 | $50.11 | $50.30 | $50.00 | +1,162% |
| August, 2030 | $49.72 | $49.68 | $49.80 | +1,152% |
| September, 2030 | $48.86 | $48.92 | $49.51 | +1,131% |
| October, 2030 | $48.19 | $48.21 | $48.59 | +1,114% |
| November, 2030 | $44.52 | $44.83 | $46.13 | +1,021% |
| December, 2030 | $42.14 | $40.70 | $43.11 | +961.53% |
3.24%
10.76%
Cap:
|
Volume (24h):